FDA Inspection 1202862 — John K. F. De Beixedon, M.D.
The FDA completed an inspection of John K. F. De Beixedon, M.D. on March 14, 2023 in Pasadena, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 14, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pasadena, CA (United States)
Additional Details
Clinical Investigator (CI)